Skip to content
Disclosery

HealthCor Management, L.P.

Follow

13F filer, CIK 1343781, NEW YORK, NY

HealthCor Management, L.P. reported $995,103,000 across 58 holdings for the quarter ended 2022-06-30, in a 13F-HR filed 2022-08-15. Its ten largest share positions make up 50.22% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001343781-22-000004

Period
2022-06-30
Reported value
$995M
Holdings
58
Top 10 weight
50.22%
New
15
Sold out
21

Largest buys vs the previous quarter

SecurityShares changeApprox. value
HOLXnew+402,110$27.9M
CInew+96,470$25.4M
LLYnew+70,630$22.9M
SEAGEN INCnew+103,060$18.2M
Anew+138,280$16.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NVSTexited-914,490-$44.5M
ABBVexited-254,160-$41.2M
TFXexited-99,150-$35.2M
ABTreduced-285,440-$31M
CVSexited-286,600-$29M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2022

Share positions as resolved from 13F-HR 0001343781-22-000004, largest first. % of portfolio is the value over $971,621,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 80,510 shares; 2021Q2: 339,300 shares; 2021Q3: 466,830 shares; 2021Q4: 453,400 shares; 2022Q1: 401,660 shares; 2022Q2: 413,640 shares 413,640$84.4M8.68%+11,980Timeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,725,650 shares; 2021Q2: 1,235,048 shares; 2021Q3: 1,278,228 shares; 2021Q4: 832,270 shares; 2022Q1: 710,110 shares; 2022Q2: 903,850 shares 903,850$72.1M7.42%+193,740
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,174,820 shares; 2021Q2: 1,210,570 shares; 2021Q3: 1,707,681 shares; 2021Q4: 1,263,670 shares; 2022Q1: 1,850,450 shares; 2022Q2: 1,807,990 shares 1,807,990$67.4M6.94%-42,460Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 227,450 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 159,320 shares; 2022Q1: 769,016 shares; 2022Q2: 740,948 shares 740,948$61.4M6.32%-28,068Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 982,630 shares; 2021Q4: 750,270 shares; 2022Q1: 634,610 shares; 2022Q2: 540,860 shares 540,860$45.8M4.71%-93,750Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 29,000 shares; 2022Q1: 72,580 shares; 2022Q2: 68,230 shares 68,230$35M3.61%-4,350Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 789,658 shares; 2021Q3: 897,646 shares; 2021Q4: 752,920 shares; 2022Q1: 1,449,536 shares; 2022Q2: 898,420 shares 898,420$31.8M3.28%-551,116Timeline
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 1,474,370 shares; 2021Q3: 3,584,160 shares; 2021Q4: 1,804,550 shares; 2022Q1: 530,160 shares; 2022Q2: 412,420 shares 412,420$31.8M3.27%-117,740Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 125,000 shares; 2021Q3: 652,150 shares; 2021Q4: 430,600 shares; 2022Q1: 502,350 shares; 2022Q2: 486,550 shares 486,550$30.4M3.13%-15,800Timeline
HOLXHOLOGIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 402,110 shares 402,110$27.9M2.87%newTimeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 376,180 shares; 2021Q3: 1,084,240 shares; 2021Q4: 782,180 shares; 2022Q1: 283,730 shares; 2022Q2: 518,990 shares 518,990$27.3M2.81%+235,260Timeline
CHEMOCENTRYX INCCHEMOCENTRYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 240,530 shares; 2022Q1: 956,740 shares; 2022Q2: 1,097,370 shares 1,097,370$27.2M2.8%+140,630
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 91,760 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 101,560 shares; 2022Q1: 73,350 shares; 2022Q2: 54,230 shares 54,230$26.2M2.69%-19,120Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 211,780 shares; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 96,470 shares 96,470$25.4M2.62%newTimeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 535,670 shares; 2021Q2: 384,920 shares; 2021Q3: not reported; 2021Q4: 150,590 shares; 2022Q1: 97,490 shares; 2022Q2: 96,880 shares 96,880$24.6M2.53%-610Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 70,630 shares 70,630$22.9M2.36%newTimeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 583,290 shares; 2021Q2: 264,340 shares; 2021Q3: 896,680 shares; 2021Q4: 520,920 shares; 2022Q1: 330,910 shares; 2022Q2: 156,910 shares 156,910$22.2M2.28%-174,000Timeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 251,390 shares; 2021Q2: 239,030 shares; 2021Q3: not reported; 2021Q4: 54,640 shares; 2022Q1: 109,040 shares; 2022Q2: 47,220 shares 47,220$22.1M2.27%-61,820Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 202,710 shares; 2022Q1: 484,740 shares; 2022Q2: 199,300 shares 199,300$21.7M2.23%-285,440Timeline
REVANCE THERAPEUTICS INCREVANCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 81,500 shares; 2021Q4: 1,449,835 shares; 2022Q1: 1,423,425 shares; 2022Q2: 1,418,088 shares 1,418,088$19.6M2.02%-5,337
HSICSCHEIN HENRY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 127,610 shares; 2022Q1: 255,230 shares; 2022Q2: 248,920 shares 248,920$19.1M1.97%-6,310Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 462,500 shares; 2021Q2: 749,310 shares; 2021Q3: 434,500 shares; 2021Q4: 94,120 shares; 2022Q1: 1,135,110 shares; 2022Q2: 485,600 shares 485,600$19.1M1.96%-649,510Timeline
SEAGEN INCSEAGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 33,890 shares; 2022Q1: not reported; 2022Q2: 103,060 shares 103,060$18.2M1.88%new
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,144,287 shares; 2021Q2: not reported; 2021Q3: 75,000 shares; 2021Q4: 108,050 shares; 2022Q1: 500,400 shares; 2022Q2: 234,130 shares 234,130$17.8M1.83%-266,270Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,371,480 shares; 2021Q2: 1,751,342 shares; 2021Q3: 1,214,670 shares; 2021Q4: 1,157,560 shares; 2022Q1: 1,180,500 shares; 2022Q2: 923,400 shares 923,400$17.8M1.83%-257,100Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 138,280 shares 138,280$16.4M1.69%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 72,490 shares 72,490$14.5M1.5%newTimeline
BDXBECTON DICKINSON & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 140,540 shares; 2021Q4: not reported; 2022Q1: 141,460 shares; 2022Q2: 55,710 shares 55,710$13.7M1.41%-85,750Timeline
UHSUNIVERSAL HLTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 325,577 shares; 2021Q3: 348,680 shares; 2021Q4: 285,620 shares; 2022Q1: 228,410 shares; 2022Q2: 134,040 shares 134,040$13.5M1.39%-94,370Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 473,330 shares; 2021Q2: 160,760 shares; 2021Q3: 442,470 shares; 2021Q4: 64,070 shares; 2022Q1: 95,800 shares; 2022Q2: 35,040 shares 35,040$11.4M1.18%-60,760Timeline
KEZAR LIFE SCIENCES INCKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 1,209,880 shares 1,209,880$10M1.03%new
THE COOPER COMPANIESTHE COOPER COMPANIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 113,167 shares; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 80,130 shares; 2022Q1: 108,590 shares; 2022Q2: 30,770 shares 30,770$9.63M0.99%-77,820
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 759,680 shares; 2021Q2: 764,330 shares; 2021Q3: 330,590 shares; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 72,020 shares 72,020$7.57M0.78%newTimeline
IBBISHARES TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 28,220 shares; 2022Q2: 53,940 shares 53,940$6.34M0.65%+25,720Timeline
HYPRHYPERFINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 691,650 shares; 2022Q1: 1,750,000 shares; 2022Q2: 2,749,400 shares 2,749,400$6.13M0.63%+999,400Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 142,110 shares; 2021Q2: 50,890 shares; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 74,780 shares 74,780$5.57M0.57%newTimeline
AFFIMED N VAFFIMED N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 1,587,944 shares; 2021Q2: 2,422,964 shares; 2021Q3: 2,555,908 shares; 2021Q4: 1,721,925 shares; 2022Q1: 1,721,925 shares; 2022Q2: 1,721,925 shares 1,721,925$4.77M0.49%0
XLVSELECT SECTOR SPDR TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 254,230 shares; 2022Q1: not reported; 2022Q2: 34,610 shares 34,610$4.44M0.46%newTimeline
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 200,000 shares; 2021Q3: 184,700 shares; 2021Q4: 181,400 shares; 2022Q1: 264,150 shares; 2022Q2: 217,165 shares 217,165$3.96M0.41%-46,985
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 499,640 shares 499,640$3.76M0.39%newTimeline
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 134,340 shares; 2022Q1: 246,540 shares; 2022Q2: 201,560 shares 201,560$3.26M0.34%-44,980Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 34,260 shares; 2021Q2: 41,080 shares; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 23,740 shares; 2022Q2: 55,280 shares 55,280$3.08M0.32%+31,540Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 60,490 shares; 2021Q2: 96,438 shares; 2021Q3: 70,898 shares; 2021Q4: 111,760 shares; 2022Q1: 111,760 shares; 2022Q2: 119,200 shares 119,200$2.7M0.28%+7,440
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 4,886,440 shares; 2021Q2: 3,248,100 shares; 2021Q3: 3,849,470 shares; 2021Q4: 2,377,130 shares; 2022Q1: 228,450 shares; 2022Q2: 239,820 shares 239,820$2.54M0.26%+11,370Timeline
IMMUNOGEN INCIMMUNOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 200,000 shares; 2021Q4: 1,310,340 shares; 2022Q1: 1,310,340 shares; 2022Q2: 500,000 shares 500,000$2.25M0.23%-810,340
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: not reported; 2022Q2: 7,150 shares 7,150$1.56M0.16%newTimeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 900,000 shares; 2022Q2: 1,000,000 shares 1,000,000$1.55M0.16%+100,000Timeline
INTRA-CELLULAR THERAPIES INCINTRA-CELLULAR THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: not reported; 2022Q1: 13,570 shares; 2022Q2: 27,070 shares 27,070$1.54M0.16%+13,500
LEAP THERAPEUTICS INCLEAP THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: 1,200,000 shares; 2021Q4: 1,066,689 shares; 2022Q1: 1,066,689 shares; 2022Q2: 1,066,689 shares 1,066,689$1.23M0.13%0
IKENA ONCOLOGY INCIKENA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: 341,212 shares; 2021Q2: 377,551 shares; 2021Q3: 339,951 shares; 2021Q4: 287,621 shares; 2022Q1: 287,621 shares; 2022Q2: 220,082 shares 220,082$975K0.1%-67,539
EQRX INCEQRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 99,998 shares; 2022Q1: 99,998 shares; 2022Q2: 99,998 shares 99,998$81K0.01%0
LONGVIEW ACQUISITION CORP IILONGVIEW ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 427,178 shares; 2021Q3: 427,178 shares; 2021Q4: 427,178 shares; 2022Q1: 427,178 shares; 2022Q2: 427,178 shares 427,178$56K0.01%0
MEDICUS SCIENCES ACQUISITIONMEDICUS SCIENCES ACQUISITIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 82,663 shares; 2021Q3: 82,663 shares; 2021Q4: 82,663 shares; 2022Q1: 82,663 shares; 2022Q2: 82,663 shares 82,663$15K<0.01%0
ORION ACQUISITION CORPORION ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: 137,305 shares; 2021Q3: 137,305 shares; 2021Q4: 137,305 shares; 2022Q1: 137,305 shares; 2022Q2: 137,305 shares 137,305$12K<0.01%0
EUCRATES BIOMEDICAL ACQU COREUCRATES BIOMEDICAL ACQU CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q3: restricted; 2020Q4: restricted; 2021Q1: not reported; 2021Q2: not reported; 2021Q3: not reported; 2021Q4: 78,059 shares; 2022Q1: 78,059 shares; 2022Q2: 78,059 shares 78,059$2K<0.01%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
BSXBOSTON SCIENTIFIC CORP COMcall500,000$18.6Mnew
CHEMOCENTRYX INCCHEMOCENTRYX INC COMcall100,000$2.48Mnew
ALGNALIGN TECHNOLOGY INC Stockcall10,000$2.37Mnew

Sold out in Q2 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST600,000$53.9Mcall
NVSTENVISTA HOLDINGS CORPORATION914,490$44.5Mshares
ABBVABBVIE INC254,160$41.2Mshares
TFXTELEFLEX INCORPORATED99,150$35.2Mshares
CVSCVS HEALTH CORP286,600$29Mshares
AMGNAMGEN INC108,890$26.3Mshares
WOOFPETCO HEALTH & WELLNESS CO I1,215,000$23.8Mshares
CAHCARDINAL HEALTH INC317,280$18Mshares
RESEARCH ALLIANCE CORP IIRESEARCH ALLIANCE CORP II1,324,800$12.9Mshares
PFEPFIZER INC242,880$12.6Mshares
HCAHCA HEALTHCARE INC48,890$12.3Mshares
SYKSTRYKER CORPORATION43,760$11.7Mshares
MRVIMARAVAI LIFESCIENCES HLDGS I200,000$7.05Mshares
REGNREGENERON PHARMACEUTICALS9,570$6.68Mshares
CANO HEALTH INCCANO HEALTH INC711,970$4.52Mshares
ALKSALKERMES PLC140,630$3.7Mshares
STXSSTEREOTAXIS INC821,850$3.07Mshares
NBIXNEUROCRINE BIOSCIENCES INC23,480$2.2Mshares
JAZZJAZZ PHARMACEUTICALS PLC9,170$1.43Mshares
PCRXPACIRA BIOSCIENCES INC13,930$1.06Mshares
PYXSPYXIS ONCOLOGY INC217,457$879Kshares

How Q2 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001343781-22-000004 base2022-08-15acceptance time not in the bulk data set